Dynavax reports fourth quarter and year end 2014 financial results
Dynavax reported the loss from operations of $91.3 million for the 2014 year end increased by $24.8 million compared to 2013. The Company had $122.7 million in cash, cash equivalents and marketable securities as of December 31, 2014. March 05, 2015